Skip to content
OpenCapital
Get started

BioCryst Pharmaceuticals BCRX Other comprehensive income/(loss)

Other comprehensive income/(loss) at other companies

Zymeworks logo
ZymeworksZYME
-$486K-189%

Other financials

Income statement

See full
Revenue$156.4M+7.5%
Gross profit$151.0M+7.1%
Operating income-$701.6M-3,405%
Net income-$721.8M-2,255,763%
EPS (diluted)-$2.98—

Balance sheet

See full
Cash & equivalents$173.4M+62.2%
Total debt$411.8M+24.7%
Total equity-$553.8M-22.6%
Total assets$465.1M-3.1%

Cash flow

See full
Operating cash flow-$61.8M-125%
CapEx$403.0K+182%
Free cash flow-$62.2M-125%

Valuation

See full
Market cap$2.37B+52.3%
Enterprise value$2.6B+46.7%
P/S2.7×-0.4×

Profitability

See full
Gross margin97.8%+0.8pp
Operating margin-43.1%-49.7pp
Net margin-51.7%-69.7pp
FCF margin35%—

Returns & leverage

See full
Return on equity-882.8%—
Debt / equity0.1×—
Current ratio1.9×-1.0×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's other comprehensive income/(loss).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioCryst Pharmaceuticals's other comprehensive income/(loss)?
BioCryst Pharmaceuticals (BCRX) reported other comprehensive income/(loss) of -$406K in Q1 2026.
How has BioCryst Pharmaceuticals's other comprehensive income/(loss) changed year-over-year?
BioCryst Pharmaceuticals's other comprehensive income/(loss) decreased by 292.4% year-over-year, from $211K to -$406K.
What is the long-term trend for BioCryst Pharmaceuticals's other comprehensive income/(loss)?
Over 2 years (2023 to 2025), BioCryst Pharmaceuticals's other comprehensive income/(loss) has grown at a -17.9% compound annual growth rate (CAGR), from $1.31M to -$883K.
What does other comprehensive income/(loss) mean?
The total of all non-owner changes in equity that are excluded from net income, such as foreign currency translation adjustments and unrealized gains or losses on investments. This provides a broader measure of financial performance beyond standard net income.